Net Income per Share - Additional Information (Detail) - shares
|
|
|
|
|
3 Months Ended |
6 Months Ended |
|
Mar. 01, 2022 |
Mar. 01, 2020 |
Mar. 01, 2019 |
Jan. 01, 2019 |
Jun. 25, 2022 |
Jun. 26, 2021 |
Jun. 25, 2022 |
Jun. 26, 2021 |
Dec. 25, 2021 |
| Earnings Per Share Note [Line Items] |
|
|
|
|
|
|
|
|
|
| Stock option outstanding |
|
|
|
|
218,229
|
|
218,229
|
|
221,354
|
| Common Class A |
|
|
|
|
|
|
|
|
|
| Earnings Per Share Note [Line Items] |
|
|
|
|
|
|
|
|
|
| Antidilutive securities excluded from computation of earnings per share |
|
|
|
|
13,000
|
20,000
|
24,000
|
13,000
|
|
| Investment Share Program |
|
|
|
|
|
|
|
|
|
| Earnings Per Share Note [Line Items] |
|
|
|
|
|
|
|
|
|
| Vesting period |
|
|
|
|
|
|
5 years
|
|
|
| Investment Share Program | Minimum |
|
|
|
|
|
|
|
|
|
| Earnings Per Share Note [Line Items] |
|
|
|
|
|
|
|
|
|
| Requirement tenure of employee for investment share program, purchase shares at discount |
|
|
|
|
|
|
1 year
|
|
|
| Discount from current market value |
|
|
|
|
|
|
20.00%
|
|
|
| Investment Share Program | Maximum |
|
|
|
|
|
|
|
|
|
| Earnings Per Share Note [Line Items] |
|
|
|
|
|
|
|
|
|
| Requirement tenure of employee for investment share program, purchase shares at discount |
|
|
|
|
|
|
2 years
|
|
|
| Discount from current market value |
|
|
|
|
|
|
40.00%
|
|
|
| Restricted Stock Awards |
|
|
|
|
|
|
|
|
|
| Earnings Per Share Note [Line Items] |
|
|
|
|
|
|
|
|
|
| Vesting period |
4 years
|
4 years
|
4 years
|
5 years
|
|
|
|
|
|
| Performance Based Awards |
|
|
|
|
|
|
|
|
|
| Earnings Per Share Note [Line Items] |
|
|
|
|
|
|
|
|
|
| Stock option outstanding |
|
|
|
|
1,348
|
|
1,348
|
|
|
| Performance Based Awards | Common Class A |
|
|
|
|
|
|
|
|
|
| Earnings Per Share Note [Line Items] |
|
|
|
|
|
|
|
|
|
| Number of shares not included because the performance criteria was not expected to be met |
|
|
|
|
|
|
17,114
|
|
|
| Unvested Performance-Based Stock Awards | Common Class A |
|
|
|
|
|
|
|
|
|
| Earnings Per Share Note [Line Items] |
|
|
|
|
|
|
|
|
|
| Antidilutive securities excluded from computation of earnings per share |
|
|
|
|
|
|
|
1,348
|
|